Morgan Stanley Knock-Out GSK/ DE000MA2SDG2 /
7/5/2022 4:45:15 PM | Chg.-0.04 | Bid6:02:44 PM | Ask6:02:44 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
10.64EUR | -0.37% | 10.64 Bid Size: 400 |
10.55 Ask Size: 12,500 |
Gsk PLC ORD 25P | 8.7547 GBP | 12/31/2078 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2